GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fabino Enterprises Ltd (BOM:543444) » Definitions » Debt-to-EBITDA

Fabino Enterprises (BOM:543444) Debt-to-EBITDA : 8.43 (As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Fabino Enterprises Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Fabino Enterprises's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₹0.0 Mil. Fabino Enterprises's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₹24.0 Mil. Fabino Enterprises's annualized EBITDA for the quarter that ended in Sep. 2024 was ₹2.8 Mil. Fabino Enterprises's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2024 was 8.43.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Fabino Enterprises's Debt-to-EBITDA or its related term are showing as below:

BOM:543444' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.45   Med: 6.21   Max: 19.76
Current: 19.76

During the past 6 years, the highest Debt-to-EBITDA Ratio of Fabino Enterprises was 19.76. The lowest was 0.45. And the median was 6.21.

BOM:543444's Debt-to-EBITDA is ranked worse than
94.36% of 674 companies
in the Drug Manufacturers industry
Industry Median: 1.67 vs BOM:543444: 19.76

Fabino Enterprises Debt-to-EBITDA Historical Data

The historical data trend for Fabino Enterprises's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fabino Enterprises Debt-to-EBITDA Chart

Fabino Enterprises Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Debt-to-EBITDA
Get a 7-Day Free Trial 3.39 4.76 0.45 7.66 11.18

Fabino Enterprises Semi-Annual Data
Mar19 Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only 0.42 8.29 4.08 -30.36 8.43

Competitive Comparison of Fabino Enterprises's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Fabino Enterprises's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fabino Enterprises's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fabino Enterprises's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Fabino Enterprises's Debt-to-EBITDA falls into.


;
;

Fabino Enterprises Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Fabino Enterprises's Debt-to-EBITDA for the fiscal year that ended in Mar. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0 + 12.691) / 1.135
=11.18

Fabino Enterprises's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0 + 23.951) / 2.842
=8.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Sep. 2024) EBITDA data.


Fabino Enterprises  (BOM:543444) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Fabino Enterprises Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Fabino Enterprises's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Fabino Enterprises Business Description

Traded in Other Exchanges
N/A
Address
Murthal Road, Shubham Garden, Jeevan Vihar Extension Near, Sonipat, HR, IND, 131001
Fabino Enterprises Ltd formerly known as Fabino Life Sciences Ltd is a pharmaceutical company. It is engaged in manufacturing, marketing, trading and packing of pharmaceutical and other wellness-focused consumer products. It offers a wide range of allopathic, Food and wellness, Veterinary, Multi-vitamin and herbal products. The company currently supplies in Haryana, Delhi, parts of Punjab, Himachal Pradesh, Eastern Uttar Pradesh, Orissa, and Jharkhand, and parts of West Bengal, Andhra Pradesh, and Nepal.

Fabino Enterprises Headlines

No Headlines